Why observational studies make sleep look more powerful than it is
Observational work links poor sleep and depression to worse health across the board. In a large Swedish register study, young people diagnosed with depression had higher risks for 66 of 69 physical diagnoses examined, including sleep disturbances, along with higher mortality [1]. That pattern is real as an association, but it bundles sleep problems together with many other things that travel with depression, so it cannot tell us how much of the poor health is caused by bad sleep.
The same study offers a caution about reading associations as causes. When it looked at childhood infections and later depression or self-harm, the increased risks largely disappeared after accounting for factors shared within families, and no strong association remained [1]. In other words, a factor that looked important in a simple comparison was mostly explained by family-level influences. That is the kind of correction that separates a genuine intervention effect from a background correlation, and it is why observational signals about sleep and infection should be treated as leads rather than settled effects.
Where a sleep intervention did show a measurable benefit
One study moved from association to intervention and found a signal worth noting. Starting melatonin treatment for sleep disturbances in children and adolescents was associated with reduced risks of self-harm among adolescent females who had depression and anxiety disorders [1]. This is a sleep intervention tied to a measurable harm outcome, and it suggests sleep treatment may be a useful component in reducing self-injurious behavior in that group [1]. The scope matters: the benefit was observed in a specific subgroup, adolescent females with depression and anxiety, not across all children or all outcomes.
That result is about self-harm, not infection or vaccination. It shows that fixing sleep can shift a health outcome in a defined population, which keeps the broader hypothesis alive, but it does not demonstrate that sleep interventions improve immune responses to infection or vaccines.
So does better sleep improve vaccination responses?
On the evidence here, that question is essentially unanswered. The vaccination mention appears only as context in a study of a sleep and mental-health program during an outbreak, and no vaccination response was measured [2]. The malaria findings concern bite prevention during sleep, not the body's response to a vaccine [3]. And the melatonin finding concerns self-harm risk, not infection or immune response [1].
What the evidence does support is narrower and more practical: protecting sleep from mosquitoes reduces malaria infection in children [3], structured programs can target sleep quality and mental health during stressful outbreaks [2], and treating sleep problems may reduce self-harm risk in a specific group of adolescent girls [1]. Whether sleep interventions improve infection outcomes or vaccination responses as strongly as observational correlations suggest remains a plausible but untested idea in these studies.
Sources used in this answer
Depression in youth and adults : etiology, outcomes, and comorbidities
In a Swedish register study, youth with depression had higher risks for most physical diagnoses including sleep disturbances, and melatonin initiation was associated with reduced self-harm risk among adolescent females with depression and anxiety.
The effectiveness of cognitive-behavioral intervention based on stress-induced immunization training on improving sleep quality and mental health of adults during …
A cognitive-behavioral stress-immunization program was examined for improving sleep quality and mental health in adults during an infectious-disease outbreak, without reporting a clear infection or vaccination outcome.
The Use of Insecticide Mosquito Nets and Insecticide Spraying on the Risk of Malaria in Children: A Meta-Analysis
A meta-analysis found that children using insecticide-treated mosquito nets had about 15% lower malaria risk and those in sprayed homes about 37% lower risk.
